Close Menu

NEW YORK (GenomeWeb) – Consumer wellness startup Onegevity Health said today that it is incorporating Gencove's low-pass genome sequencing and analytics into its service.

Under the partnership, Gencove, a spinout from the New York Genome Center, will provide its low-pass sequencing solution to Onegevity's multi-omic artificial intelligence platform and services. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.